相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production
H. Takaki et al.
MUCOSAL IMMUNOLOGY (2018)
Toll-like receptor 2 ligand and interferon-gamma suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
Hiroaki Shime et al.
ONCOIMMUNOLOGY (2018)
Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b+ Ly6G+ intratumor myeloid cells through the TICAM-1 signaling pathway
Hiroaki Shime et al.
CELL DEATH AND DIFFERENTIATION (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways
Alessandra Zevini et al.
TRENDS IN IMMUNOLOGY (2017)
A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy
Yohei Takeda et al.
CELL REPORTS (2017)
PD-L1 immune suppression in cancer: Tumor cells or host cells?
Jan Willem Kleinovink et al.
ONCOIMMUNOLOGY (2017)
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade
Simon J. Dovedi et al.
CLINICAL CANCER RESEARCH (2017)
Tumor vaccines with dsRNA adjuvant ARNAX induces antigen-specific tumor shrinkage without cytokinemia
Tsukasa Seya et al.
ONCOIMMUNOLOGY (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy
Masahiro Azuma et al.
ONCOIMMUNOLOGY (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Viral RNA detection by RIG-I-like receptors
Mitsutoshi Yoneyama et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
Misako Matsumoto et al.
NATURE COMMUNICATIONS (2015)
Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Tetje C. van der Sluis et al.
CLINICAL CANCER RESEARCH (2015)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Activated STING in a Vascular and Pulmonary Syndrome
Y. Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Andrea Schietinger et al.
TRENDS IN IMMUNOLOGY (2014)
Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation
Austin Pantel et al.
PLOS BIOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1
Nicholas T. Redpath et al.
BIOCHEMICAL JOURNAL (2013)
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Cutting Edge: IL-12 and Type I IFN Differentially Program CD8 T Cells for Programmed Death 1 Re-expression Levels and Tumor Control
Michael Y. Gerner et al.
JOURNAL OF IMMUNOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA
Megumi Tatematsu et al.
NATURE COMMUNICATIONS (2013)
ssDNA-dsRNAs are cleaved at the next to its chimera-junction point by an unknown RNase activity
Shinichi Mochizuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Paul Sabbatini et al.
CLINICAL CANCER RESEARCH (2012)
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
Hiroaki Shime et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Cross-priming for antitumor CTL induced by soluble Ag plus polyI:C depends on the TICAM-1 pathway in mouse CD11c+/CD8α+ dendritic cells
Masahiro Azuma et al.
ONCOIMMUNOLOGY (2012)
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination
Christophe J. Desmet et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection
Ivett Jelinek et al.
JOURNAL OF IMMUNOLOGY (2011)
New adjuvants for human vaccines
M. Lamine Mbow et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
A Molecular Mechanism for Toll-IL-1 Receptor Domain-containing Adaptor Molecule-1-mediated IRF-3 Activation
Megumi Tatematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Sarah L. Jongbloed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
Lionel Franz Poulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
Tsukasa Seya et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
TLR3:: Interferon induction by double-stranded RNA including poly(I:C)
Misako Matsumoto et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-β production
Kiyoharu Itoh et al.
JOURNAL OF IMMUNOLOGY (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Arthur M. Krieg et al.
IMMUNOLOGICAL REVIEWS (2007)
Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA
Kenji Funami et al.
JOURNAL OF IMMUNOLOGY (2007)
Differential type IIFN-Inducing abilities of wild-type versus vaccine strains of measles virus
Masashi Shingai et al.
JOURNAL OF IMMUNOLOGY (2007)
Essential role of mda-5 in type IIFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus
Leonid Gitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
H Kato et al.
NATURE (2006)
Chemokines: more than just road signs
MF Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
Toll-like receptor 3 promotes cross-priming to virus-infected cells
O Schulz et al.
NATURE (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
M Yamamoto et al.
SCIENCE (2003)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction
H Oshiumi et al.
NATURE IMMUNOLOGY (2003)
Subcellular localization of toll-like receptor 3 in human dendritic cells. (vol 171, pg 3154, 2003)
M Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2003)
分享论文
